DOJ Announces $1.2 Million Settlement with Respironics
On September 22, 2022, the United States Department of Justice (DOJ) announced a $1.2 million settlement with Philips RS North…
Author
Drug Utilization Management Impacts Physician Treatment Decisions,…
A study recently published in PLOS ONE found that drug utilization management impacts physician treatment decisions and can lead…
The Importance of Private Funding to Biopharmaceutical Development
In early September 2022, a study was published regarding The Relative Contributions of NIH and Private Sector Funding to the…
HHS to Invest Nearly $60 Million in Rural Health Care Communities
Earlier this year, the United States Department of Health and Human Services (HHS) announced a nearly $60 million investment in…
HHS Issues Guidance on Audio-Only Telehealth
Earlier this year, the United States Department of Health and Human Services (HHS) issued guidance to explain how audio-only…
Biogen $900 Million Settlement Agreement Finalized
We previously reported about Biogen’s $900 million settlement to resolve claims brought by a former employee that Biogen illegally…
OPDP Releases Proposed Collections of Information Regarding DTC Advertising
The United States Food and Drug Administration (FDA) recently published several notices that the Office of Prescription Drug…
Third Interim Final Rule for No Surprises Act Now Published
On August 26, 2022, the U.S. Departments of Health and Human Services (HHS), Labor and the Treasury (the Departments) have issued…
CMS Issues Final Rule for Oncology and Outpatient Site Payments
The Biden administration has finalized a rule that indefinitely delays the controversial radiation oncology payment model, which…
Teva Faces Lawsuit Over Copaxone Marketing
In late August 2022, Blue Cross and Blue Shield of Vermont and the Vermont Health Plan filed a lawsuit against Teva…